Feasibility and efficacy of gemcitabine plus cisplatin combination therapy after curative resection for biliary tract cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1868-6982|22|11|789-794

ISSN： 1868-6974

Source： JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol.22, Iss.11, 2015-11, pp. : 789-794

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Renal Toxicity Associated with Weekly Cisplatin and Gemcitabine Combination Therapy for Treatment of Advanced Biliary Tract Cancer

By  

Oncology, Vol. 87, Iss. 1, 2014-06 ,pp. : 30-39

Karger

Access to resources Recommend Favorite

Phase I study of gemcitabine, cisplatin, and S‐1 combination therapy for patients with untreated advanced biliary tract cancer

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 9, 2015-09 ,pp. : 669-674

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 8, 2018-04 ,pp. : 1671-1675

John Wiley & Sons Inc

Access to resources Recommend Favorite

Second‐line chemotherapy for advanced biliary tract cancer after failure of the gemcitabine‐platinum combination: A large multicenter study by the Association des Gastro‐Entérologues Oncologues

By  

CANCER, Vol. 121, Iss. 18, 2015-09 ,pp. : 3290-3297

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patterns of Initial Disease Recurrence after Resection of Biliary Tract Cancer

By  

Oncology, Vol. 83, Iss. 2, 2012-07 ,pp. : 83-90

Karger

Access to resources Recommend Favorite